149 related articles for article (PubMed ID: 21044313)
1. Identification of a variant form of tyrosine phosphatase LYP.
Wang S; Dong H; Han J; Ho WT; Fu X; Zhao ZJ
BMC Mol Biol; 2010 Nov; 11():78. PubMed ID: 21044313
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp.
Cohen S; Dadi H; Shaoul E; Sharfe N; Roifman CM
Blood; 1999 Mar; 93(6):2013-24. PubMed ID: 10068674
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.
Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X
PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725
[TBL] [Abstract][Full Text] [Related]
4. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
[TBL] [Abstract][Full Text] [Related]
6. A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.
Orrú V; Tsai SJ; Rueda B; Fiorillo E; Stanford SM; Dasgupta J; Hartiala J; Zhao L; Ortego-Centeno N; D'Alfonso S; ; Arnett FC; Wu H; Gonzalez-Gay MA; Tsao BP; Pons-Estel B; Alarcon-Riquelme ME; He Y; Zhang ZY; Allayee H; Chen XS; Martin J; Bottini N
Hum Mol Genet; 2009 Feb; 18(3):569-79. PubMed ID: 18981062
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the
Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
[TBL] [Abstract][Full Text] [Related]
9. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
Gianchecchi E; Palombi M; Fierabracci A
Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816
[TBL] [Abstract][Full Text] [Related]
10. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
11. The potential of PTPN22 as a therapeutic target for rheumatoid arthritis.
Carmona FD; Martín J
Expert Opin Ther Targets; 2018 Oct; 22(10):879-891. PubMed ID: 30251905
[TBL] [Abstract][Full Text] [Related]
12. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.
Walton ZE; Bishop AC
Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
14. Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.
Karver MR; Krishnamurthy D; Bottini N; Barrios AM
J Inorg Biochem; 2010 Mar; 104(3):268-73. PubMed ID: 20083307
[TBL] [Abstract][Full Text] [Related]
15. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.
Vang T; Landskron J; Viken MK; Oberprieler N; Torgersen KM; Mustelin T; Tasken K; Tautz L; Rickert RC; Lie BA
Hum Immunol; 2013 May; 74(5):574-85. PubMed ID: 23333624
[TBL] [Abstract][Full Text] [Related]
16. Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.
Perri V; Pellegrino M; Ceccacci F; Scipioni A; Petrini S; Gianchecchi E; Lo Russo A; De Santis S; Mancini G; Fierabracci A
PLoS One; 2017; 12(4):e0175784. PubMed ID: 28437437
[TBL] [Abstract][Full Text] [Related]
17. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
[TBL] [Abstract][Full Text] [Related]
18. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1.
Reddy MV; Johansson M; Sturfelt G; Jönsen A; Gunnarsson I; Svenungsson E; Rantapää-Dahlqvist S; Alarcón-Riquelme ME
Genes Immun; 2005 Dec; 6(8):658-62. PubMed ID: 16052172
[TBL] [Abstract][Full Text] [Related]
19. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation.
Hill RJ; Zozulya S; Lu YL; Ward K; Gishizky M; Jallal B
Exp Hematol; 2002 Mar; 30(3):237-44. PubMed ID: 11882361
[TBL] [Abstract][Full Text] [Related]
20. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.
Dai X; James RG; Habib T; Singh S; Jackson S; Khim S; Moon RT; Liggitt D; Wolf-Yadlin A; Buckner JH; Rawlings DJ
J Clin Invest; 2013 May; 123(5):2024-36. PubMed ID: 23619366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
